Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Medical Necessity of L4-5 Fusion with Cage and Autograft

Patient Selection and Clinical Presentation

  • The American College of Surgeons recommends that patients with persistent low back pain, degenerative disc disease, and Modic changes that have failed conservative management are candidates for L4-5 fusion with cage and autograft 1
  • Patients with a history of prior lumbar discectomy and worsening symptoms despite conservative management may benefit from L4-5 fusion with cage and autograft 1

Evidence Supporting Interbody Fusion

  • Interbody techniques are associated with higher fusion rates (89-95%) compared to posterolateral fusion alone in patients with degenerative disc disease limited to one or two levels 3, 4
  • The use of cages in interbody fusion provides better structural support and maintains disc height compared to fusion without cages 5

Evidence Supporting Autograft Use

  • Autograft has osteogenic, osteoinductive, and osteoconductive properties that promote solid fusion 6
  • Using the patient's own tissue eliminates concerns about disease transmission or immunologic rejection that might occur with allograft materials 6

Inpatient vs. Ambulatory Setting

  • The MCG guidelines classify L4-5 fusion procedures as appropriate for ambulatory surgery 1
  • Single-level lumbar fusion procedures can be safely performed in an outpatient setting with appropriate patient selection 2
  • The patient does not require inpatient admission for L4-5 fusion with cage and autograft unless they have documented comorbidities that require extended monitoring beyond what can be provided in an ambulatory setting 2